Just a moment...

Top
Help
×

By creating an account you can:

Logo TaxTMI
>
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
Add to...
You have not created any category. Kindly create one to bookmark this item!
Create New Category
Hide
Title :
Description :
+ Post an Article
Post a New Article
Title :
0/200 char
Description :
Max 0 char
Category :
Co Author :

In case of Co-Author, You may provide Username as per TMI records

Delete Reply

Are you sure you want to delete your reply beginning with '' ?

Delete Issue

Are you sure you want to delete your Issue titled: '' ?

Articles

Back

All Articles

whatsappJoin Channel
Advanced Search
Reset Filters
Search By:
Search by Text :
Press 'Enter' to add multiple search terms
Select Date:
FromTo
Category :
Sort By:
Relevance Date

Patent Registration and Enforcement: A Comparative Study of India, the United States, and the European Union

YAGAY and SUN
Comparative patent enforcement balances innovation incentives, public welfare, injunction standards, pharmaceutical protection and FRAND obligations across major systems. Patent registration and enforcement in India, the United States and the European Union differ in patentability, examination, enforcement and public-interest policy. India requires novelty, inventive step and industrial applicability, excludes specified subject matter, and restricts evergreening through its public-interest framework. The United States follows a first-inventor-to-file system with automatic examination and stronger commercialisation incentives. The European framework combines European Patent Office prosecution with European Patent, Unitary Patent and Unified Patent Court mechanisms. Enforcement may involve injunctions, damages and other remedies, with differing standards concerning equity, proportionality, public interest and FRAND obligations. (AI Summary)

Abstract

Patent protection is a cornerstone of intellectual property law, granting inventors exclusive rights over their inventions for a limited period in order to encourage innovation, technological advancement, and economic growth. Although the fundamental objective of patent law is universally similar, the legal frameworks governing patent registration, enforcement, infringement, and remedies differ considerably across jurisdictions.

India, the United States (US), and the European Union (EU) have developed distinct patent systems reflecting their respective legal traditions, economic priorities, and public policy objectives. India's patent regime emphasizes public welfare and access to medicines, whereas the United States provides comparatively broader patent protection to stimulate innovation and investment. The European Union follows a harmonized yet decentralized model through the European Patent Convention (EPC), complemented by the emerging Unified Patent Court (UPC).

This article critically examines and compares patent registration procedures, enforcement mechanisms, litigation frameworks, available remedies, and landmark judicial decisions across these three jurisdictions. It concludes with recommendations for strengthening India's patent system while maintaining an appropriate balance between innovation and public interest.

Keywords: Patent Registration, Patent Enforcement, Comparative Patent Law, India, United States, European Union, Intellectual Property Rights, TRIPS Agreement

1. Introduction

Patents represent one of the most valuable forms of intellectual property because they reward inventors with exclusive rights to commercially exploit their inventions for a limited period-generally twenty years from the filing date.

Patent protection serves several important objectives:

  • Encourages research and development (R&D)
  • Promotes technological innovation
  • Attracts domestic and foreign investment
  • Facilitates technology transfer
  • Stimulates economic development

Although the TRIPS Agreement establishes minimum standards of patent protection, member states retain considerable flexibility in designing their own patent systems.

Among the world's leading patent regimes, India, the United States, and the European Union illustrate three distinct policy approaches toward balancing innovation, competition, and public welfare.

2. Patent Registration: Comparative Framework

2.1 India

Patent registration in India is governed by the Patents Act, 1970, as amended in 1999, 2002, and 2005 to ensure compliance with TRIPS.

Table 1: Patentability Requirements in India

Requirement

Description

Novelty

The invention must be new worldwide.

Inventive Step

Must involve technical advancement and not be obvious to a skilled person.

Industrial Applicability

Must be capable of industrial use.

Table 2: Non-Patentable Subject Matter under Section 3

Excluded Subject Matter

Relevant Provision

Discoveries

Section 3(c)

Mathematical methods

Section 3(k)

Business methods

Section 3(k)

Computer programs per se

Section 3(k)

Traditional knowledge

Section 3(p)

Medical treatment methods

Section 3(i)

New forms of known substances without enhanced efficacy

Section 3(d)

The Controller of Patents examines applications and grants patents having a validity period of 20 years.

2.2 United States

Patent protection in the United States is governed by Title 35 of the United States Code and administered by the United States Patent and Trademark Office (USPTO).

Patentable Subject Matter

Patent Category

Processes

Machines

Manufactures

Compositions of Matter

Improvements thereof

The America Invents Act (2011) replaced the first-to-invent system with a first-inventor-to-file system.

2.3 European Union

The European Union grants patents primarily through the European Patent Convention (EPC) administered by the European Patent Office (EPO).

Key developments include:

  • European Patent
  • Unitary Patent
  • Unified Patent Court (UPC)

These mechanisms simplify patent protection across participating EU member states.

3. Comparative Patent Registration Procedure

Exhibit 1: Patent Registration Process

Stage

India

United States

European Union

Filing Authority

Indian Patent Office

USPTO

European Patent Office

Publication

After 18 months

Generally after 18 months

After 18 months

Examination

On request

Automatic

On request

Granting Authority

Controller of Patents

USPTO

EPO

Patent Duration

20 Years

20 Years

20 Years

4. Patent Enforcement

Patent enforcement safeguards inventors against unauthorized commercial exploitation of patented inventions.

Table 3: Enforcement Framework

Feature

India

United States

European Union

Governing Law

Patents Act, Commercial Courts Act, CPC

Patent Act (35 U.S.C.)

National Laws + EPC + UPC

Court

Commercial Courts/High Courts

Federal District Courts

National Courts/UPC

Administrative Review

Limited

PTAB

Opposition before EPO

Table 4: Available Remedies

Remedy

India

United States

European Union

Interim Injunction

 

 

 

Permanent Injunction

 

 

 

Damages

 

 

 

Account of Profits

 

Limited

Available in some jurisdictions

Product Recall

Limited

Occasionally

 

Destruction of Goods

 

 

 

Attorney's Fees

Rare

Exceptional Cases

Limited

5. Patent Infringement

Patent infringement occurs when a patented invention is:

  • Made
  • Used
  • Sold
  • Imported
  • Offered for sale

without authorization.

Table 5: Types of Patent Infringement

Type

India

US

EU

Direct Infringement

 

 

 

Indirect Infringement

Limited

 

 

Literal Infringement

 

 

 

Doctrine of Equivalents

Limited

Extensive

Moderate

India primarily emphasizes claim construction and statutory interpretation.

6. Injunctions

Table 6: Standards for Granting Injunctions

India

United States

European Union

Prima facie case

Irreparable injury

Infringement established

Balance of convenience

Inadequate legal remedy

Proportionality

Irreparable injury

Balance of hardships

Interests of third parties

Public interest

Public interest

FRAND obligations where applicable

7. Pharmaceutical Patents

Table 7: Comparative Pharmaceutical Patent Protection

Feature

India

United States

European Union

Evergreening

Restricted (Section 3(d))

Generally permitted

Limited

Secondary Patents

Restricted

Allowed

Allowed

Patent Term Extension

No

Limited

SPC Available

Regulatory Exclusivity

Limited

Yes

Yes


8. Standard Essential Patents (SEPs)

Table 8: SEP Regulation

India

United States

European Union

FRAND emphasized

FRAND + Antitrust

Detailed FRAND Framework

Judicial determination

Contractual approach

Huawei v. ZTE principles

9. Landmark Judicial Decisions

Table 9: India

Case

Principle Established

Novartis AG v. Union of India (2013)

Section 3(d); anti-evergreening

F. Hoffmann-La Roche Ltd. v. Cipla Ltd.

Public interest in pharmaceutical injunctions

Ericsson v. Micromax

Recognition of FRAND licensing

Table 10: United States

Case

Principle

Diamond v. Chakrabarty

Biotechnology patentability

eBay v. MercExchange

Four-factor injunction test

Alice Corp. v. CLS Bank

Software patent eligibility

Table 11: European Union

Case

Principle

Huawei v. ZTE

FRAND negotiations before injunction

Improver Corp. v. Remington

Doctrine of Equivalents


10. Comparative Analysis

Exhibit 2: Comparative Features

Feature

India

United States

European Union

Governing Law

Patents Act, 1970

Patent Act (35 U.S.C.)

EPC

Patent Office

Indian Patent Office

USPTO

EPO

Patent Term

20 Years

20 Years

20 Years

Evergreening

Restricted

Permissive

Limited

Software Patents

Restricted

Limited after Alice

Technical contribution required

Injunction Test

Equitable + Public Interest

Four-factor test

Proportionality

Compulsory Licensing

Available

Rare

Limited

11. Challenges

Table 12: Major Challenges

India

United States

European Union

Examination delays

High litigation costs

Multi-jurisdiction litigation

Shortage of examiners

Patent trolls

Translation costs

Technical litigation

PTAB challenges

UPC transition

Judicial backlog

Expensive enforcement

National coordination

12. Recommendations

Table 13: Policy Recommendations

Recommendation

Expected Impact

Increase patent examiners

Reduce pendency

Strengthen IP benches

Improve judicial efficiency

Promote ADR

Faster dispute resolution

Enhance digital systems

Transparent administration

International cooperation

Better harmonization

Increase awareness among startups and universities

Higher patent filings and commercialization

13. Critical Evaluation

The three jurisdictions represent distinct philosophical approaches to patent law.

Jurisdiction

Primary Policy Objective

India

Public welfare and affordable healthcare

United States

Innovation, commercialization, and investment

European Union

Harmonization and regional integration

India's use of Section 3(d) and compulsory licensing demonstrates a deliberate effort to balance private intellectual property rights with constitutional commitments to public health. The United States provides robust protection for inventors while relying on equitable principles to moderate enforcement. The European Union seeks consistency through the EPC and the Unified Patent Court, although national differences remain relevant.

Rather than identifying a single 'best' model, the comparative analysis suggests that each jurisdiction has evolved to meet its own economic and social priorities. India can further strengthen its patent ecosystem by improving administrative efficiency, reducing examination delays, expanding judicial expertise, and encouraging commercialization, while preserving its public-interest safeguards.

14. Conclusion

Patent registration and enforcement remain fundamental to fostering innovation, technological progress, and sustainable economic development. Although India, the United States, and the European Union all comply with the minimum standards prescribed by the TRIPS Agreement, their legal systems differ significantly in relation to patentability, enforcement mechanisms, pharmaceutical patents, software inventions, injunctions, and available remedies.

India has developed a distinctive patent regime that balances private intellectual property rights with broader public-interest considerations, particularly in healthcare. The United States continues to provide strong incentives for innovation and investment while tempering enforcement through equitable judicial principles. The European Union combines centralized patent prosecution with progressively unified enforcement through the Unified Patent Court.

As innovation becomes increasingly global, greater international cooperation, procedural harmonization, and institutional strengthening will be essential to ensure that patent law continues to promote technological advancement while safeguarding societal welfare.

References

Primary Legislation and International Instruments

Judicial Decisions

The Patents Act, 1970 (India)

Novartis AG Versus Union of India and others - 2013 (4) TMI 348 - Supreme Court

The Patents Rules, 2003

F. Hoffmann-La Roche Ltd. v. Cipla Ltd.

TRIPS Agreement, 1994

Telefonaktiebolaget LM Ericsson v. Micromax Informatics Ltd.

European Patent Convention, 1973

Diamond v. Chakrabarty, 447 U.S. 303 (1980)

Patent Act, 35 U.S.C.

eBay Inc. v. MercExchange, 547 U.S. 388 (2006)

Commercial Courts Act, 2015

Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014)

Enforcement Directive 2004/48/EC

Huawei Technologies Co. Ltd. v. ZTE Corp., C-170/13 (CJEU, 2015)

Unified Patent Court Agreement

Improver Corp. v. Remington Consumer Products Ltd.

***

answers
Sort by
+ Add A New Reply
Hide
+ Add A New Reply
Hide
Recent Articles